Oramed Pharmaceuticals Inc. (ORMP) was a big mover last session, as the company saw its shares rise over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company since Jun 11, as the stock is now trading above the volatile price range of $5.38 to $7.40.
In the last 30 days, the company has seen one negative estimate revision and its Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Oramed Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is positive.
A better-ranked med products stock is Bio-Rad Laboratories, Inc. (BIO) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment